-
1
-
-
17344384668
-
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
-
A.B. Sandler, J. Nemunaitis, C. Denham, J. von Pawel, Y. Cormier, U. Gatzemeier, K. Mattson, C. Manegold, M.C. Palmer, A. Gregor, B. Nguyen, C. Niyikiza, and L.H. Einhorn Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer J. Clin. Oncol. 18 2000 122 130 (Pubitemid 30036345)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.1
, pp. 122-130
-
-
Sandler, A.B.1
Nemunaitis, J.2
Denham, C.3
Von Pawel, J.4
Cormier, Y.5
Gatzemeier, U.6
Mattson, K.7
Manegold, Ch.8
Palmer, M.C.9
Gregor, A.10
Nguyen, B.11
Niyikiza, C.12
Einhorn, L.H.13
-
2
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: A randomized trial
-
H.A. Burris 3rd, M.J. Moore, J. Andersen, M.R. Green, M.L. Rothenberg, M.R. Modiano, M.C. Cripps, R.K. Portenoy, A.M. Storniolo, P. Tarassoff, R. Nelson, F.A. Dorr, C.D. Stephens, and D.D. Von Hoff Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J. Clin. Oncol. 15 1997 2403 2413 (Pubitemid 27251144)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.6
, pp. 2403-2413
-
-
Burris III, H.A.1
Moore, M.J.2
Andersen, J.3
Green, M.R.4
Rothenberg, M.L.5
Modiano, M.R.6
Cripps, M.C.7
Portenoy, R.K.8
Storniolo, A.M.9
Tarassoff, P.10
Nelson, R.11
Dorr, F.A.12
Stephens, C.D.13
Von Hoff, D.D.14
-
3
-
-
0033857218
-
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study
-
H. von der Maase, S.W. Hansen, J.T. Roberts, L. Dogliotti, T. Oliver, M.J. Moore, I. Bodrogi, P. Albers, A. Knuth, C.M. Lippert, P. Kerbrat, P. Sanchez Rovira, P. Wersall, S.P. Cleall, D.F. Roychowdhury, I. Tomlin, C.M. Visseren-Grul, and P.F. Conte Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J. Clin. Oncol. 18 2000 3068 3077
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 3068-3077
-
-
Von Der Maase, H.1
Hansen, S.W.2
Roberts, J.T.3
Dogliotti, L.4
Oliver, T.5
Moore, M.J.6
Bodrogi, I.7
Albers, P.8
Knuth, A.9
Lippert, C.M.10
Kerbrat, P.11
Sanchez Rovira, P.12
Wersall, P.13
Cleall, S.P.14
Roychowdhury, D.F.15
Tomlin, I.16
Visseren-Grul, C.M.17
Conte, P.F.18
-
4
-
-
15544361947
-
Gemcitabine and paclitaxel in metastatic breast cancer: A review
-
R. Colomer Gemcitabine and paclitaxel in metastatic breast cancer: a review Oncology (Williston Park) 18 2004 8 12
-
(2004)
Oncology (Williston Park)
, vol.18
, pp. 8-12
-
-
Colomer, R.1
-
5
-
-
0033959650
-
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group
-
DOI 10.1006/gyno.1999.5671
-
R.J. Schilder, J.A. Blessing, M. Morgan, C.E. Mangan, and J.S. Rader Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group Gynecol. Oncol. 76 2000 204 207 (Pubitemid 30067196)
-
(2000)
Gynecologic Oncology
, vol.76
, Issue.2
, pp. 204-207
-
-
Schilder, R.J.1
Blessing, J.A.2
Morgan, M.3
Mangan, C.E.4
Rader, J.S.5
-
6
-
-
0033957908
-
A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix
-
DOI 10.1006/gyno.1999.5657
-
A.F. Burnett, L.D. Roman, A.A. Garcia, L.I. Muderspach, K.R. Brader, and C.P. Morrow A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix Gynecol. Oncol. 76 2000 63 66 (Pubitemid 30048321)
-
(2000)
Gynecologic Oncology
, vol.76
, Issue.1
, pp. 63-66
-
-
Burnett, A.F.1
Roman, L.D.2
Garcia, A.A.3
Muderspach, L.I.4
Brader, K.R.5
Morrow, C.P.6
-
7
-
-
0027076297
-
Phase II study of gemcitabine in advanced colorectal adenocarcinoma
-
DOI 10.1007/BF00944189
-
D.F. Moore Jr., R. Pazdur, K. Daugherty, P. Tarassoff, and J.L. Abbruzzese Phase II study of gemcitabine in advanced colorectal adenocarcinoma Invest. New Drugs 10 1992 323 325 (Pubitemid 23008982)
-
(1992)
Investigational New Drugs
, vol.10
, Issue.4
, pp. 323-325
-
-
Moore Jr., D.F.1
Pazdur, R.2
Daugherty, K.3
Tarassoff, P.4
Abbruzzese, J.L.5
-
8
-
-
1642471800
-
Mechanisms of apoptosis induction by nucleoside analogs
-
DOI 10.1038/sj.onc.1207229, Apoptosis - Part 2
-
D. Sampath, V.A. Rao, and W. Plunkett Mechanisms of apoptosis induction by nucleoside analogs Oncogene 22 2003 9063 9074 (Pubitemid 38121707)
-
(2003)
Oncogene
, vol.22
, Issue.56 REV. ISSUE 8
, pp. 9063-9074
-
-
Sampath, D.1
Rao, V.A.2
Plunkett, W.3
-
9
-
-
33947430594
-
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs
-
DOI 10.1007/s10555-007-9044-4, Special Issue on Transporters in Cancer
-
J. Zhang, F. Visser, K.M. King, S.A. Baldwin, J.D. Young, and C.E. Cass The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs Cancer Metastasis Rev. 26 2007 85 110 (Pubitemid 46452184)
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.1
, pp. 85-110
-
-
Zhang, J.1
Visser, F.2
King, K.M.3
Baldwin, S.A.4
Young, J.D.5
Cass, C.E.6
-
10
-
-
0036462584
-
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
-
A.M. Bergman, H.M. Pinedo, and G.J. Peters Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) Drug Resist. Updat. 5 2002 19 33
-
(2002)
Drug Resist. Updat.
, vol.5
, pp. 19-33
-
-
Bergman, A.M.1
Pinedo, H.M.2
Peters, G.J.3
-
11
-
-
0025978216
-
A phase i clinical, plasma, and cellular pharmacology study of gemcitabine
-
J.L. Abbruzzese, R. Grunewald, E.A. Weeks, D. Gravel, T. Adams, B. Nowak, S. Mineishi, P. Tarassoff, W. Satterlee, and M.N. Raber A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J. Clin. Oncol. 9 1991 491 498
-
(1991)
J. Clin. Oncol.
, vol.9
, pp. 491-498
-
-
Abbruzzese, J.L.1
Grunewald, R.2
Weeks, E.A.3
Gravel, D.4
Adams, T.5
Nowak, B.6
Mineishi, S.7
Tarassoff, P.8
Satterlee, W.9
Raber, M.N.10
-
12
-
-
33846178254
-
Squalenoyl nanomedicines as potential therapeutics
-
DOI 10.1021/nl061942q
-
P. Couvreur, B. Stella, L.H. Reddy, H. Hillaireau, C. Dubernet, D. Desmaele, S. Lepetre-Mouelhi, F. Rocco, N. Dereuddre-Bosquet, P. Clayette, V. Rosilio, V. Marsaud, J.M. Renoir, and L. Cattel Squalenoyl nanomedicines as potential therapeutics Nano Lett. 6 2006 2544 2548 (Pubitemid 46076946)
-
(2006)
Nano Letters
, vol.6
, Issue.11
, pp. 2544-2548
-
-
Couvreur, P.1
Stella, B.2
Harivardhan Reddy, L.3
Hillaireau, H.4
Dubernet, C.5
Desmaeie, D.6
Lepetre-Mouelhi, S.7
Rocco, F.8
Dereuddre-Bosquet, N.9
Clayette, P.10
Rosilio, V.11
Marsaud, V.12
Renoir, J.-M.13
Cattel, L.14
-
13
-
-
36148942471
-
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types
-
DOI 10.1016/j.jconrel.2007.08.018, PII S0168365907004245
-
L.H. Reddy, C. Dubernet, S.L. Mouelhi, P.E. Marque, D. Desmaele, and P. Couvreur A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types J. Control Release 124 2007 20 27 (Pubitemid 350103730)
-
(2007)
Journal of Controlled Release
, vol.124
, Issue.1-2
, pp. 20-27
-
-
Reddy, L.H.1
Dubernet, C.2
Mouelhi, S.L.3
Marque, P.E.4
Desmaele, D.5
Couvreur, P.6
-
14
-
-
54249120139
-
Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: Study of mechanisms
-
L.H. Reddy, H. Ferreira, C. Dubernet, S.L. Mouelhi, D. Desmaele, B. Rousseau, and P. Couvreur Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms Anticancer Drugs 19 2008 999 1006
-
(2008)
Anticancer Drugs
, vol.19
, pp. 999-1006
-
-
Reddy, L.H.1
Ferreira, H.2
Dubernet, C.3
Mouelhi, S.L.4
Desmaele, D.5
Rousseau, B.6
Couvreur, P.7
-
15
-
-
77958103576
-
Extracellular-protein-enhanced cellular uptake of squalenoyl gemcitabine from nanoassemblies
-
L. Bildstein, V. Marsaud, H. Chacun, S. Lepetre-Mouelhi, D. Desmaele, P. Couvreur, and C. Dubernet Extracellular-protein-enhanced cellular uptake of squalenoyl gemcitabine from nanoassemblies Soft Matter 6 2010 5570 5580
-
(2010)
Soft Matter
, vol.6
, pp. 5570-5580
-
-
Bildstein, L.1
Marsaud, V.2
Chacun, H.3
Lepetre-Mouelhi, S.4
Desmaele, D.5
Couvreur, P.6
Dubernet, C.7
-
16
-
-
77953810106
-
Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: Coupled DSC and XRD study
-
B. Pili, C. Bourgaux, H. Amenitsch, G. Keller, S. Lepetre-Mouelhi, D. Desmaele, P. Couvreur, and M. Ollivon Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study Biochim. Biophys. Acta 1798 2010 1522 1532
-
(2010)
Biochim. Biophys. Acta
, vol.1798
, pp. 1522-1532
-
-
Pili, B.1
Bourgaux, C.2
Amenitsch, H.3
Keller, G.4
Lepetre-Mouelhi, S.5
Desmaele, D.6
Couvreur, P.7
Ollivon, M.8
-
17
-
-
77957017332
-
Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: An original drug delivery pathway
-
L. Bildstein, C. Dubernet, V. Marsaud, H. Chacun, V. Nicolas, C. Gueutin, A. Sarasin, H. Benech, S. Lepetre-Mouelhi, D. Desmaele, and P. Couvreur Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway J. Control. Release: Off. J. Control. Release Soc. 147 2010 163 170
-
(2010)
J. Control. Release: Off. J. Control. Release Soc.
, vol.147
, pp. 163-170
-
-
Bildstein, L.1
Dubernet, C.2
Marsaud, V.3
Chacun, H.4
Nicolas, V.5
Gueutin, C.6
Sarasin, A.7
Benech, H.8
Lepetre-Mouelhi, S.9
Desmaele, D.10
Couvreur, P.11
-
18
-
-
0034707095
-
Surface active drugs: Self-association and interaction with membranes and surfactants. Physicochemical and biological aspects
-
S. Schreier, S.V. Malheiros, and E. de Paula Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects Biochim. Biophys. Acta 1508 2000 210 234
-
(2000)
Biochim. Biophys. Acta
, vol.1508
, pp. 210-234
-
-
Schreier, S.1
Malheiros, S.V.2
De Paula, E.3
-
19
-
-
34147123081
-
Changes in erythrocyte morphology induced by imipramine and chlorpromazine
-
H. Ahyayaucha, M. Gallego, O. Casis, and M. Bennouna Changes in erythrocyte morphology induced by imipramine and chlorpromazine J. Physiol. Biochem. 62 2006 199 205
-
(2006)
J. Physiol. Biochem.
, vol.62
, pp. 199-205
-
-
Ahyayaucha, H.1
Gallego, M.2
Casis, O.3
Bennouna, M.4
-
20
-
-
33749339541
-
Emulsions of oil from Adenanthera pavonina L. seeds and their protective effect
-
DOI 10.2478/s11658-006-0037-z
-
A. Jaromin, R. Zarnowski, and A. Kozubek Emulsions of oil from Adenanthera pavonina L. seeds and their protective effect Cell Mol. Biol. Lett. 11 2006 438 448 (Pubitemid 44492473)
-
(2006)
Cellular and Molecular Biology Letters
, vol.11
, Issue.3
, pp. 438-448
-
-
Jaromin, A.1
Zarnowski, R.2
Kozubek, A.3
-
21
-
-
53949109830
-
Membrane perturbing properties of natural phenolic and resorcinolic lipids
-
M. Stasiuk, and A. Kozubek Membrane perturbing properties of natural phenolic and resorcinolic lipids FEBS Lett. 582 2008 3607 3613
-
(2008)
FEBS Lett.
, vol.582
, pp. 3607-3613
-
-
Stasiuk, M.1
Kozubek, A.2
-
22
-
-
80053999479
-
The lipid distribution of posthemolytic residue or stroma of erythrocytes
-
B.N. Erickson, H.H. Williams, S.S. Bernstein, I. Avrin, R.L. Jones, and I.G. Macy The lipid distribution of posthemolytic residue or stroma of erythrocytes J. Biol. Chem. 122 1938 515 528
-
(1938)
J. Biol. Chem.
, vol.122
, pp. 515-528
-
-
Erickson, B.N.1
Williams, H.H.2
Bernstein, S.S.3
Avrin, I.4
Jones, R.L.5
MacY, I.G.6
-
23
-
-
0014189244
-
Membrane lipid depletion in hyperpermeable red blood cells: Its role in the genesis of spherocytes in hereditary spherocytosis
-
H. Jacob, and S. Lowry Membrane lipid depletion in hyperpermeable red blood cells: its role in the genesis of spherocytes in hereditary spherocytosis J. Clin. Invest. 46 1967 2083 2094
-
(1967)
J. Clin. Invest.
, vol.46
, pp. 2083-2094
-
-
Jacob, H.1
Lowry, S.2
-
24
-
-
77049139811
-
Fractions related to experimental conditions red cell stroma in dogs: Variations in the stroma protein and lipid
-
G. Tishkoff, F. Robscheit-Robbins, and G. Whipple Fractions related to experimental conditions red cell stroma in dogs: variations in the stroma protein and lipid Blood 8 1953 459 468
-
(1953)
Blood
, vol.8
, pp. 459-468
-
-
Tishkoff, G.1
Robscheit-Robbins, F.2
Whipple, G.3
-
27
-
-
0002992946
-
Calorimetric studies on phospholipid-water systems: I. - Dipalmitoylphosphatidylcholine (DPPC)-water system
-
C. Grabielle-Madelmont, and R. Perron Calorimetric studies on phospholipid-water systems: I. - Dipalmitoylphosphatidylcholine (DPPC)-water system J. Colloid Interface Sci. 95 1983 471 482
-
(1983)
J. Colloid Interface Sci.
, vol.95
, pp. 471-482
-
-
Grabielle-Madelmont, C.1
Perron, R.2
-
28
-
-
70350761684
-
Interaction of an anticancer drug, gemcitabine, with phospholipid bilayers
-
B. Pili, C. Bourgaux, F. Meneau, P. Couvreur, and M. Ollivon Interaction of an anticancer drug, gemcitabine, with phospholipid bilayers J. Therm. Anal. Calorim. 98 2009 19 28
-
(2009)
J. Therm. Anal. Calorim.
, vol.98
, pp. 19-28
-
-
Pili, B.1
Bourgaux, C.2
Meneau, F.3
Couvreur, P.4
Ollivon, M.5
-
29
-
-
39449128320
-
Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue
-
DOI 10.1002/smll.200700731
-
P. Couvreur, L.H. Reddy, S. Mangenot, J.H. Poupaert, D. Desmaele, S. Lepetre-Mouelhi, B. Pili, C. Bourgaux, H. Amenitsch, and M. Ollivon Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue Small 4 2008 247 253 (Pubitemid 351271158)
-
(2008)
Small
, vol.4
, Issue.2
, pp. 247-253
-
-
Couvreur, P.1
Reddy, L.H.2
Mangenot, S.3
Poupaert, J.H.4
Desmaele, D.5
Lepetre-Mouelhi, S.6
Pili, B.7
Bourgaux, C.8
Amenitsch, H.9
Ollivon, M.10
-
30
-
-
56749158321
-
Novel PEGylated nanoassemblies made of self assembled squalenoyl nucleoside analogues
-
F. Bekkara Aounallah, R. Gref, M. Othman, L.H. Reddy, B. Pili, V. Allain, C. Bourgaux, H. Hillaireau, S. Lepêtre Mouelhi, and D. Desmaële Novel PEGylated nanoassemblies made of self assembled squalenoyl nucleoside analogues Adv. Funct. Mater. 18 2008 3715 3725
-
(2008)
Adv. Funct. Mater.
, vol.18
, pp. 3715-3725
-
-
Bekkara Aounallah, F.1
Gref, R.2
Othman, M.3
Reddy, L.H.4
Pili, B.5
Allain, V.6
Bourgaux, C.7
Hillaireau, H.8
Lepêtre Mouelhi, S.9
Desmaële, D.10
-
31
-
-
0001243166
-
Sponge phases in surfactant solutions
-
D. Roux, C. Coulon, and M. Cates Sponge phases in surfactant solutions J. Phys. Chem. 96 1992 4174 4187
-
(1992)
J. Phys. Chem.
, vol.96
, pp. 4174-4187
-
-
Roux, D.1
Coulon, C.2
Cates, M.3
-
32
-
-
33847013731
-
Morphological transitions in model membrane systems by the addition of anesthetics
-
M. Baciu, M.C. Holmes, and M.S. Leaver Morphological transitions in model membrane systems by the addition of anesthetics J. Phys. Chem. B 111 2007 909 917
-
(2007)
J. Phys. Chem. B
, vol.111
, pp. 909-917
-
-
Baciu, M.1
Holmes, M.C.2
Leaver, M.S.3
-
33
-
-
33745626462
-
Role of gemcitabine in ovarian cancer treatment
-
DOI 10.1093/annonc/mdj979
-
D. Lorusso, A. Di Stefano, F. Fanfani, and G. Scambia Role of gemcitabine in ovarian cancer treatment Ann. Oncol. 17 Suppl. 5 2006 v188 v194 (Pubitemid 43985232)
-
(2006)
Annals of Oncology
, vol.17
, Issue.SUPPL. 5
-
-
Lorusso, A.1
Di Stefano, A.2
Fanfani, F.3
Scambia, G.4
-
34
-
-
0035426936
-
Cell cycle effects of gemcitabine
-
DOI 10.1002/ijc.1351
-
P. Cappella, D. Tomasoni, M. Faretta, M. Lupi, F. Montalenti, F. Viale, F. Banzato, M. D'Incalci, and P. Ubezio Cell cycle effects of gemcitabine Int. J. Cancer 93 2001 401 408 (Pubitemid 32592060)
-
(2001)
International Journal of Cancer
, vol.93
, Issue.3
, pp. 401-408
-
-
Cappella, P.1
Tomasoni, D.2
Faretta, M.3
Lupi, M.4
Montalenti, F.5
Viale, F.6
Banzato, F.7
D'Incalci, M.8
Ubezio, P.9
-
35
-
-
0032998028
-
Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines
-
DOI 10.1016/S0959-8049(98)00425-0, PII S0959804998004250
-
C. Tolis, G.J. Peters, C.G. Ferreira, H.M. Pinedo, and G. Giaccone Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines Eur. J. Cancer 35 1999 796 807 (Pubitemid 29258151)
-
(1999)
European Journal of Cancer
, vol.35
, Issue.5
, pp. 796-807
-
-
Tolis, C.1
Peters, G.J.2
Ferreira, C.G.3
Pinedo, H.M.4
Giaccone, G.5
-
36
-
-
0037322664
-
Radiation enhancement by gemcitabine-mediated cell cycle modulations
-
DOI 10.1097/00000421-200302000-00013
-
S. Mose, R. Class, H.W. Weber, A. Rahn, L.W. Brady, and H.D. Bottcher Radiation enhancement by gemcitabine-mediated cell cycle modulations Am. J. Clin. Oncol. 26 2003 60 69 (Pubitemid 36205899)
-
(2003)
American Journal of Clinical Oncology: Cancer Clinical Trials
, vol.26
, Issue.1
, pp. 60-69
-
-
Mose, S.1
Class, R.2
Weber, H.-W.3
Rahn, A.4
Brady, L.W.5
Bottcher, H.D.6
-
37
-
-
0034326813
-
The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine
-
L.J. Ostruszka, and D.S. Shewach The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine Cancer Res. 60 2000 6080 6088
-
(2000)
Cancer Res.
, vol.60
, pp. 6080-6088
-
-
Ostruszka, L.J.1
Shewach, D.S.2
-
38
-
-
0035209928
-
Gemcitabine activity in cervical cancer cell lines
-
DOI 10.1007/s002800100370
-
P. Hernandez, P. Olivera, A. Duenas-Gonzalez, M.A. Perez-Pastenes, A. Zarate, V. Maldonado, and J. Melendez-Zajgla Gemcitabine activity in cervical cancer cell lines Cancer Chemother. Pharmacol. 48 2001 488 492 (Pubitemid 33139871)
-
(2001)
Cancer Chemotherapy and Pharmacology
, vol.48
, Issue.6
, pp. 488-492
-
-
Hernandez, P.1
Olivera, P.2
Duenas-Gonzalez3
Perez-Pastenes, M.A.4
Zarate, A.5
Maldonado, V.6
Melendez-Zajgla, J.7
-
39
-
-
0026324313
-
Action of 2′,2′-difluorodeoxycytidine on DNA synthesis
-
P. Huang, S. Chubb, L.W. Hertel, G.B. Grindey, and W. Plunkett Action of 2′,2′-difluorodeoxycytidine on DNA synthesis Cancer Res. 51 1991 6110 6117
-
(1991)
Cancer Res.
, vol.51
, pp. 6110-6117
-
-
Huang, P.1
Chubb, S.2
Hertel, L.W.3
Grindey, G.B.4
Plunkett, W.5
-
40
-
-
0026571795
-
Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: A mechanism of self-potentiation
-
V. Heinemann, Y.Z. Xu, S. Chubb, A. Sen, L.W. Hertel, G.B. Grindey, and W. Plunkett Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: a mechanism of self-potentiation Cancer Res. 52 1992 533 539
-
(1992)
Cancer Res.
, vol.52
, pp. 533-539
-
-
Heinemann, V.1
Xu, Y.Z.2
Chubb, S.3
Sen, A.4
Hertel, L.W.5
Grindey, G.B.6
Plunkett, W.7
-
41
-
-
0017405105
-
The noneffect of a large linear hydrocarbon, squalene, on the phosphatidylcholine packing structure
-
S.A. Simon, L.J. Lis, R.C. MacDonald, and J.W. Kauffman The noneffect of a large linear hydrocarbon, squalene, on the phosphatidylcholine packing structure Biophys. J. 19 1977 83 90 (Pubitemid 8125348)
-
(1977)
Biophysical Journal
, vol.19
, Issue.1
, pp. 83-90
-
-
Simon, S.A.1
Lis, L.J.2
MacDonald, R.C.3
Kauffman, J.W.4
-
42
-
-
72749127071
-
Buffers may adversely affect model lipid membranes: A cautionary tale
-
T. Peiro -Salvador, O. Ces, R.H. Templer, and A.M. Seddon Buffers may adversely affect model lipid membranes: a cautionary tale Biochemistry 48 2009 11149 11151
-
(2009)
Biochemistry
, vol.48
, pp. 11149-11151
-
-
Peiro -Salvador, T.1
Ces, O.2
Templer, R.H.3
Seddon, A.M.4
-
43
-
-
0030853508
-
Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity
-
DOI 10.1021/bi962785k
-
E. Prenner, R. Lewis, K. Neuman, S. Gruner, L. Kondejewski, R. Hodges, and R. McElhaney Nonlamellar phases induced by interaction of Gramicidin S with lipid bilayers; a possible relationship to membrane-disrupting activity Biochemistry 36 1997 7906 7916 (Pubitemid 27287204)
-
(1997)
Biochemistry
, vol.36
, Issue.25
, pp. 7906-7916
-
-
Prenner, E.J.1
Lewis, R.N.A.H.2
Neuman, K.C.3
Gruner, S.M.4
Kondejewski, L.H.5
Hodges, R.S.6
McElhaney, R.N.7
-
44
-
-
42449100440
-
Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine
-
DOI 10.1124/jpet.107.133751
-
L.H. Reddy, P.E. Marque, C. Dubernet, S.L. Mouelhi, D. Desmaele, and P. Couvreur Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine J. Pharmacol. Exp. Ther. 325 2008 484 490 (Pubitemid 351574820)
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.325
, Issue.2
, pp. 484-490
-
-
Reddy, L.H.1
Marque, P.-E.2
Dubernet, C.3
Mouelhi, S.-L.4
Desmaele, D.5
Couvreur, P.6
-
45
-
-
39049146634
-
Management of venous port systems in oncology: A review of current evidence
-
S. Vescia, A.K. Baumgartner, V.R. Jacobs, M. Kiechle-Bahat, A. Rody, S. Loibl, and N. Harbeck Management of venous port systems in oncology: a review of current evidence Ann. Oncol. 19 2008 9 15
-
(2008)
Ann. Oncol.
, vol.19
, pp. 9-15
-
-
Vescia, S.1
Baumgartner, A.K.2
Jacobs, V.R.3
Kiechle-Bahat, M.4
Rody, A.5
Loibl, S.6
Harbeck, N.7
|